The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.
Department of Medicine, Queen Mary Hospital, Hong Kong, China.
Harinder
H
Gill
Department of Medicine, Queen Mary Hospital, Hong Kong, China.
Garret M K
GM
Leung
Serviço de Hematologia, Centro Hospitalar Conde De S. Januario, Macau, China.
David
D
Lopes
Department of Medicine, Queen Mary Hospital, Hong Kong, China.
Yok-Lam
YL
Kwong
D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000188:drug therapy; D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000494:pharmacology / Q000627:therapeutic use*; D055815:Young Adult
D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag
aplastic anaemia; eltrombopag; romiplostim; treatment